Concepedia
Statistics
Publications
21
Citations
2.1K
H-Index
19
Active since
1980
Affiliations
Eisai (United States)(Current)
Eisai (Japan)
University of British Columbia
Rush University Medical Center
Nebraska Medical Center
Melvyn Lynn is an author at Eisai (United States) specializing in pharmacology, clinical pharmacology, and life sciences.
Publications per year
1980–2013
Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis
Steven M. Opal, Pierre‐François Laterre, Bruno François et al. · JAMA · 2013 · 795 citations · Full text
Veterinary Medicine, Pharmacology, Pharmacotherapy +11
Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis*
Mark Tidswell, William Tillis, Steven P. LaRosa et al. · Critical Care Medicine · 2009 · 226 citations
Medicine, Immunology, Pharmacology +17
Blocking of Responses to Endotoxin by E5564 in Healthy Volunteers with Experimental Endotoxemia
Melvyn Lynn, Daniel P. Rossignol, Janice L. Wheeler et al. · The Journal of Infectious Diseases · 2003 · 151 citations · Full text
Veterinary Medicine, Immunology, Pharmacology +12
Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site
W. Gong, Darryl B. Neill, Melvyn Lynn et al. · Neuroscience · 1999 · 90 citations
Life Sciences, Neuroscience, Pharmacology +17
A lipid A analog, E5531, blocks the endotoxin response in human volunteers with experimental endotoxemia
Eugene Bunnell, Melvyn Lynn, Kalim Habet et al. · Critical Care Medicine · 2000 · 84 citations
Veterinary Medicine, Pharmacology, Pharmacotherapy +9
1–5 of 21